Pierce Atwood litigation partner Kathleen Hamann, a former FCPA prosecutor, will join other former DOJ officials in a session discussing the future of FCPA investigations and enforcement, and the special considerations for pharmaceutical, medical device and biotech companies, and CROs.
The speakers will share their insights on DOJ and SEC enforcement postures and priorities, and the evolving landscape of risk for life sciences companies.
Please visit ACI for more information.
Kathleen Hamann is an internationally recognized authority in the field of white collar enforcement and compliance matters. Drawing on her nearly 20 years of service to the federal government, in roles at the U.S. Department of Justice and Department of State, Kate helps clients navigate the complexities of U.S. and transnational criminal liability and multijurisdictional government investigations.